Article
Characterization of tiacumicin B biosynthetic gene cluster affording diversified tiacumicin analogues and revealing a tailoring dihalogenase.
Journal of the American Chemical Society - 2 Feb 2011
Xiao Yi, Li Sumei, Niu Siwen, Ma Liang, Zhang Guangtao, Zhang Haibo, Zhang Gaiyun, Ju Jianhua, Zhang Changsheng
Abstract excerpt
The RNA polymerase inhibitor tiacumicin B is currently undergoing phase III clinical trial for treatment of Clostridium difficile associated diarrhea with great promise. To understand the biosynthetic logic and to lay a foundation for generating structural analogues via pathway engineering, the tiacumicin B biosynthetic gene cluster was identified and characterized from the producer Dactylosporangium aurantiacum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
